Sectoral Asset Management Inc Cti Biopharma Corp Transaction History

Sectoral Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$4.2 - $6.01 $1.15 Million - $1.64 Million	273,000 Added 27.85%	1,253,300 $5.26 Million
Q4 2022 Feb 10, 2023	BUY	$4.45 - $6.17 $53,400 - $74,040	12,000 Added 1.24%	980,300 $5.89 Million
Q3 2022 Nov 10, 2022	BUY	$5.36 - $7.43 $5.19 Million - $7.19 Million	968,300 New	968,300 $5.64 Million
Q4 2018 Feb 12, 2019	SELL	$0.73 - $2.19 $23,535 - $70,607	-32,241 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.72 - $5.24 $55,454 - $168,942	32,241 New	32,241 $70,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.